{"id":"https://openalex.org/W3006239533","doi":"https://doi.org/10.1097/cad.0000000000000910","title":"Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61","display_name":"Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61","publication_year":2020,"publication_date":"2020-02-14","ids":{"openalex":"https://openalex.org/W3006239533","doi":"https://doi.org/10.1097/cad.0000000000000910","mag":"3006239533","pmid":"https://pubmed.ncbi.nlm.nih.gov/32044796"},"language":"en","primary_location":{"id":"doi:10.1097/cad.0000000000000910","doi":"https://doi.org/10.1097/cad.0000000000000910","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000910","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032325513","display_name":"Taha Koray \u015eahin","orcid":"https://orcid.org/0000-0002-3590-0426","observed_orcids":["https://orcid.org/0000-0002-3590-0426"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Taha Koray Sahin","raw_affiliation_strings":["Department of Internal Medicine, Faculty of Medicine, Hacettepe University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Faculty of Medicine, Hacettepe University","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038532420","display_name":"Oktay Halit Aktepe","orcid":"https://orcid.org/0000-0003-3540-0701","observed_orcids":["https://orcid.org/0000-0003-3540-0701"]},"institutions":[{"id":"https://openalex.org/I4210115551","display_name":"Hacettepe University Hospital","ror":"https://ror.org/024q5j973","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210115551"]},{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Oktay Halit Aktepe","raw_affiliation_strings":["Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey","institution_ids":["https://openalex.org/I4210115551","https://openalex.org/I66514158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091381226","display_name":"Fatih Mehmet Uckun","orcid":"https://orcid.org/0000-0001-9334-183X","observed_orcids":["https://orcid.org/0000-0001-9334-183X"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fatih Mehmet Uckun","raw_affiliation_strings":["Children\u2019s Center for Cancer and Blood Diseases, Children\u2019s Hospital Los Angeles","Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Center for Cancer and Blood Diseases, Children\u2019s Hospital Los Angeles","institution_ids":["https://openalex.org/I1336910626"]},{"raw_affiliation_string":"Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, California, USA","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076720762","display_name":"\u015euayib Yal\u00e7\u0131n","orcid":"https://orcid.org/0000-0001-7850-6798","observed_orcids":["https://orcid.org/0000-0001-7850-6798"]},"institutions":[{"id":"https://openalex.org/I4210115551","display_name":"Hacettepe University Hospital","ror":"https://ror.org/024q5j973","country_code":"TR","type":"healthcare","lineage":["https://openalex.org/I4210115551"]},{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Suayib Yalcin","raw_affiliation_strings":["Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey","institution_ids":["https://openalex.org/I4210115551","https://openalex.org/I66514158"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5032325513"],"corresponding_institution_ids":["https://openalex.org/I66514158"],"apc_list":null,"apc_paid":null,"fwci":0.2812,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.57194337,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"31","issue":"6","first_page":"609","last_page":"616"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9365000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9365000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.05700000002980232,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/syk","display_name":"Syk","score":0.8799999952316284},{"id":"https://openalex.org/keywords/syk-inhibitors","display_name":"SYK inhibitors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/nanoformulations","display_name":"nanoformulations","score":0.8410000205039978},{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cisplatin-combination-therapy","display_name":"cisplatin combination therapy","score":0.8679999709129333},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.953000009059906},{"id":"https://openalex.org/keywords/caspase-activation","display_name":"caspase activation","score":0.9549999833106995},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.6899999976158142},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.9139999747276306},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.8619999885559082},{"id":"https://openalex.org/keywords/p27","display_name":"p27","score":0.8149999976158142},{"id":"https://openalex.org/keywords/cyclin-d1","display_name":"cyclin D1","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.8759999871253967},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.9440000057220459}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6784024834632874},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6274787187576294},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5719916820526123},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5522345900535583},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.551514744758606},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5494682788848877},{"id":"https://openalex.org/C35174551","wikidata":"https://www.wikidata.org/wiki/Q7660502","display_name":"Syk","level":4,"score":0.5062671899795532},{"id":"https://openalex.org/C199835354","wikidata":"https://www.wikidata.org/wiki/Q15311861","display_name":"Cyclin D1","level":4,"score":0.47491252422332764},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.44565629959106445},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4373953938484192},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38433295488357544},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37666255235671997},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3633911609649658},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.36256223917007446},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32220640778541565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19277995824813843},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.18020427227020264},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14466330409049988},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1190628707408905},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08819246292114258}],"mesh":[{"descriptor_ui":"D000072377","descriptor_name":"Syk Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/cad.0000000000000910","doi":"https://doi.org/10.1097/cad.0000000000000910","is_oa":false,"landing_page_url":"https://doi.org/10.1097/cad.0000000000000910","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:32044796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32044796","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3965094191","display_name":"Amplifying Radiation Potency Against Leukemic Stem Cells","funder_award_id":"R21CA164098","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5008851319","display_name":"Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL","funder_award_id":"R01CA154471","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G858553711","display_name":"Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles","funder_award_id":"U01CA151837","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W257159349","https://openalex.org/W1604468403","https://openalex.org/W1892479582","https://openalex.org/W1978503888","https://openalex.org/W1980123375","https://openalex.org/W1987295322","https://openalex.org/W2004094156","https://openalex.org/W2005894094","https://openalex.org/W2013050167","https://openalex.org/W2017341404","https://openalex.org/W2024087814","https://openalex.org/W2063708209","https://openalex.org/W2070061120","https://openalex.org/W2087963041","https://openalex.org/W2104036704","https://openalex.org/W2106315111","https://openalex.org/W2108471741","https://openalex.org/W2112305498","https://openalex.org/W2121485819","https://openalex.org/W2121619780","https://openalex.org/W2136816306","https://openalex.org/W2138853586","https://openalex.org/W2139216034","https://openalex.org/W2150273441","https://openalex.org/W2157999078","https://openalex.org/W2162560910","https://openalex.org/W2251349015","https://openalex.org/W2262087934","https://openalex.org/W2264936833","https://openalex.org/W2508243160","https://openalex.org/W2540537925","https://openalex.org/W2591051430","https://openalex.org/W2727380696","https://openalex.org/W2737284239","https://openalex.org/W2770686393","https://openalex.org/W2783197533","https://openalex.org/W2803225056","https://openalex.org/W2899379471","https://openalex.org/W2910348924","https://openalex.org/W2911188335","https://openalex.org/W3024248917","https://openalex.org/W3147725646","https://openalex.org/W6609597002","https://openalex.org/W6633658626","https://openalex.org/W6667962191","https://openalex.org/W6693113569","https://openalex.org/W6747567546"],"related_works":["https://openalex.org/W2324597359","https://openalex.org/W2165637874","https://openalex.org/W2330062027","https://openalex.org/W4405408914","https://openalex.org/W2237173037","https://openalex.org/W2006196568","https://openalex.org/W7163339480","https://openalex.org/W2026350172","https://openalex.org/W4223544043","https://openalex.org/W2333363042"],"abstract_inverted_index":{"Patients":[0],"with":[1,67,77,141],"advanced":[2],"or":[3,74],"metastatic":[4],"castration-resistant":[5,32,185,243],"prostate":[6,33,186,244],"cancer":[7,187],"have":[8],"a":[9,27,48,228,237],"dismal":[10],"prognosis":[11],"and":[12,83,138,153,160,176,204,208],"are":[13,221],"therefore":[14],"in":[15,75,101,133,149,163,195,202],"urgent":[16],"need":[17],"for":[18,31,80,241],"therapeutic":[19],"innovations.":[20],"Spleen":[21],"tyrosine":[22,51,231],"kinase":[23,52,232],"has":[24],"emerged":[25],"as":[26,119,121,144,146,227,234],"new":[28],"molecular":[29],"target":[30],"cancer.":[34,245],"This":[35],"study":[36],"was":[37,89],"done":[38],"to":[39,223],"test":[40],"the":[41,44,56,150,166,184,215],"cytotoxicity":[42,114,182],"of":[43,47,70,97,136,158,165,198,236],"lead":[45],"nanoformulation":[46],"potent":[49],"spleen":[50,230],"inhibitor,":[53],"C61-LNP,":[54,118],"against":[55,115,183],"human":[57],"prostatic":[58],"carcinoma":[59],"cell":[60,87,167,188,205],"line,":[61],"PC-3.":[62],"PC-3":[63,103,116],"cells":[64,104],"were":[65,105,211],"treated":[66,102],"various":[68,98],"concentrations":[69],"C61-LNP":[71,111,122,159,180,226],"either":[72],"alone":[73],"combination":[76,157],"cisplatin":[78],"(CDDP)":[79],"24,":[81],"48":[82],"72":[84],"hours.":[85],"The":[86,156],"viability":[88],"evaluated":[90,106],"by":[91,107,214],"MTS":[92],"assay.":[93],"Cellular":[94],"expression":[95,196],"levels":[96,197],"regulatory":[99,169,199],"proteins":[100,170,200],"Western":[108],"blot":[109],"analyses.":[110],"exhibited":[112,181],"dose-dependent":[113],"cells.":[117],"well":[120,145],"+":[123],"CDDP":[124,161],"treatments,":[125],"caused":[126,193],"pro-apoptotic":[127],"proteomic":[128],"changes":[129],"including":[130],"an":[131,147],"increase":[132],"cleaved":[134],"fragments":[135],"caspases-3":[137],"-9":[139],"consistent":[140],"caspase":[142],"activation":[143],"improvement":[148],"anti-apoptotic":[151],"Bcl2":[152],"Bax":[154],"levels.":[155,179],"changed":[162],"alterations":[164,194],"cycle":[168,206],"p53,":[171],"p21,":[172],"p27,":[173],"cyclin":[174,177],"D1":[175],"E":[178],"line":[189],"PC3.":[190],"It":[191],"also":[192],"involved":[201],"apoptosis":[203],"regulation":[207],"these":[209],"effects":[210],"not":[212],"abrogated":[213],"standard":[216],"chemotherapy":[217],"drug":[218],"CDDP.":[219],"We":[220],"planning":[222],"further":[224],"develop":[225],"selective":[229],"inhibitor":[233],"part":[235],"multi-modality":[238],"treatment":[239],"strategy":[240],"advanced/metastatic":[242]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-02-24T00:00:00"}